Loading clinical trials...
Loading clinical trials...
A Phase 1, Multiple-Dose, Open-Label Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 5222 (Cefepime and Zidebactam) in Healthy Adult Human Subjects
Conditions
Interventions
FEP-ZID
Locations
1
United States
Pulmonary Associates
Phoenix, Arizona, United States
Start Date
March 31, 2017
Primary Completion Date
June 30, 2017
Completion Date
July 30, 2017
Last Updated
August 14, 2018
Lead Sponsor
Wockhardt
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions